The pyrogenic effect of scarlet fever toxin. II. Leukocytic pyrogen formation induced by scarlet fever toxin or Salmonella paratyphi B endotoxin

Tissue cages for study of experimental streptococcal infection in rabbits. III. Influence of immunization with erythrogenic toxin type A (ET A) and its toxoid on subsequent infection with an ET A producing strain

Purified erythrogenic toxin type A (ET A) and the corresponding toxoid, prepared by formalin treatment, were used for the immunization of rabbits (200 micrograms per rabbit). The impact of anti-erythrogenic toxin and toxoid immunity was investigated under the conditions of experimental infection with the ET A-producing Streptococcus pyogenes strain SF 130 (type 1). Whereas non of the immunized rabbits (n = 14) died after infection, 40% of nonimmunized animals did not survive (Table 1). The increase of the spleen weight after infection was significantly smaller in the immunized groups (Table 2). The immunized rabbits responded after infection with a significantly lower increase of fever which did not exceed 0.8 degree C (2 degrees C in infected non-immunized animals). Humoral antibodies to ET A were detected after immunization by means of ELISA. The challenge infection acted as a booster leading to a further increase of antibodies. The antibodies were found to be neutralizing the nonspecific mitogenicity of ET A in vitro in relation to the antibody titer. Cell-mediated immunity was tested in the lymphocyte transformation reaction with peripheral lymphocytes. The nonspecific mitogenicity of ET A, ET B, ET C and Con A was pronounced after immunization, whereas the nonimmunized rabbits responded to these antigens to a lower degree. The toxoid was found to be nonmitogenic. The altogether higher lymphocyte stimulation was also observed using spleen lymphocytes of immunized animals after infection.

Molecular basis of fever in humans

This review presents several areas of research on the pathogenesis of fever in humans and updates new information concerning the role of fever in host defense mechanisms. Fever is mediated by a polypeptide of phagocytic cell origin called leukocytic pyrogen. Several agents and disease processes are associated with the synthesis and release of leukocytic pyrogen. Although the original studies on leukocytic pyrogen suggested that the neutrophil was the primary source, recent experiments indicate the mononuclear phagocyte to be the major producer of leukocytic pyrogen. The mechanism by which human monocytes are stimulated to produce leukocytic pyrogen is discussed, including the effects of corticosteroids, estrogens and antipyretics on the synthesis of leukocytic pyrogen in vitro. The ability of leukocytic pyrogen to alter the hypothalamic thermoregulatory center by increasing arachidonic acid metabolite levels is the most likely mechanism by which leukocytic pyrogen initiates fever. Antipyretics prevent the synthesis of certain cyclooxygenase metabolites, which accounts for their ability to reduce fever. Studies on the chemical and physical properties of human leukocytic pyrogen are reviewed and form the basis for current experiments on the similarities between leukocytic pyrogen and lymphocyte activating factor. These studies suggest that leukocytic pyrogen, in addition to producing fever, also stimulates non-hypothalamic cells involved in aspects of the acute-phase response. In this regard, leukocytic pyrogen may be an important mechanism for host defenses. Hyperthermia may also be beneficial to the host but is distinct from fever; the role of leukocytic pyrogen as well as hyperthermia as a defense mechanism is discussed.

Influence of antilymphocyte and antipolymorphonuclear sera on the pyrogenic effect of scarlet fever toxin

The role played by lymphocytes in the pyretic response to scarlet fever toxin (ET) was studied in vivo using antilymphocyte serum (ALS). Two i.v. injections of ALS inhibited the pyretic response to a subsequent ET injection in rabbits. The course of endotoxin fever remained uninfluenced by ALS. Antipolymorphonuclear serum had no effect on the pyretic response to either of the toxins. Pretreatment with ALS also inhibited the skin reaction after i.d. injection of ET. These findings are further evidence a mediating role of lymphocytes in the biological effects of ET, among other things in the release of endogenous pyrogen.